Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.
Open Access
- 1 June 1994
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (22) , 15898-15905
- https://doi.org/10.1016/s0021-9258(17)40765-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionPublished by Elsevier ,2003
- Determination of the disulfide bridges in factor Va light chainBiochemistry, 1993
- Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.Journal of Clinical Investigation, 1992
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factorsNeuron, 1991
- Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting regionBiochemistry, 1990
- Activation of human factor V by factor Xa and thrombinBiochemistry, 1990
- Structure of human factor VIIINature, 1984
- Characterization of the human factor VIII geneNature, 1984
- Hemorrhagic death associated with a high titer factor V inhibitorAmerican Journal of Hematology, 1978